Riskpilot← Back to searchSign inGet full accessUnilabs Diagnostics AB
ABActiveOrg 5567225072Anderstorpsvägen 10Activities of holding companies · NACE 6421Est. 20071-4 employees
Revenue 2024
SEK 0
EBITDA margin
—
+51% vs 2023
Equity ratio
34.8%
Financial strength
Net profit 2024
SEK -270,8M
-17% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -4,4M | +51% |
| Net profit | SEK -270,8M | -17% |
| Total assets | SEK 31,8B | +7% |
| Equity | SEK 11,1B | +156% |
| Employees | — | — |
Legal name
Unilabs Diagnostics AB
Org number
5567225072
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
1 februari 2007
Share capital
SEK 20 122 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Bolaget har till föremål för sin verksamhet att, direkt eller indirekt, äga och förvalta fast och lös egendom såsom fastigheter och värdepapper, samt därmed förenlig verksamhet.
Address
Anderstorpsvägen 10
Email
redovisning@unilabs.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −2 354 | −5 501 | −1 407 | −6 937 | −3 489 | 5 198 | −48 381 | −10 121 | −9 077 | −4 446 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −2 354 | −5 501 | −1 407 | −6 937 | −3 489 | 5 198 | −48 381 | −10 121 | −9 077 | −4 446 |
| Net financials | −131 344 | −225 803 | −111 469 | −287 646 | −101 031 | 11 049 | −81 358 | 68 899 | −296 430 | −396 218 |
| Profit before tax | 1 902 | −50 104 | −112 549 | −137 093 | −22 315 | 264 796 | 93 841 | −9 398 | −267 680 | −170 178 |
| Tax | −0 | 50 300 | 45 000 | 21 500 | −65 125 | −18 584 | −47 715 | −346 133 | 36 273 | −100 621 |
| Net profit | 1 902 | 196 | −67 549 | −115 593 | −87 440 | 246 212 | 46 126 | −355 531 | −231 407 | −270 799 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10 400 357 | 11 294 171 | 19 231 657 | 23 154 249 | 24 670 338 | 23 511 529 | 25 096 271 | 30 518 508 | 29 705 079 | 31 812 969 |
| Equity | 2 881 309 | 2 881 505 | 3 747 476 | 3 631 882 | 3 604 344 | 2 561 636 | 1 125 360 | 2 255 735 | 4 317 487 | 11 063 344 |
| Long-term debt | 7 353 053 | 8 018 217 | 15 110 233 | 18 304 818 | 19 158 648 | 19 345 037 | 22 033 707 | 23 642 689 | 22 710 194 | 18 116 507 |
| Short-term debt | 165 995 | 394 449 | 373 949 | 1 217 549 | 1 850 609 | 1 604 856 | 1 934 611 | 4 273 930 | 2 378 638 | 2 225 842 |
| Total debt | 7 519 048 | 8 412 666 | 15 484 182 | 19 522 367 | 21 009 257 | 20 949 893 | 23 968 318 | 27 916 619 | 25 088 832 | 20 342 349 |
EBITDA margin
-444600000.0%
This company
15.8%
Market median
-2813924151% vs market
20152024
Equity ratio
34.8%
This company
38.2%
Market median
+9% vs market
20152024
Return on equity
-2.4%
This company
18.4%
Market median
-113% vs market
20152024
Net profit margin
-27079900000.0%
This company
8.1%
Market median
-334319753186% vs market
20152024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20152024
Debt / equity
1.88×
This company
0.62×
Market median
-203% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RB Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AL Chief Auditor | Chief Auditor | 2025 | — | — |
MY Authorized Recipient of Service | Authorized Recipient of Service | 2025 | — | — |
JD Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
LP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
EM Chief Auditor | Chief Auditor | 2022 | — | — |
AG Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
UL SWE I AB | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
UNILABS GROUP HOLDING APSUL SWE I AB
Unilabs Diagnostics AB (this company)Unilabs SaRimed AgUnilabs Holding Czech Republic S.R.oProxills SaUnilabs Nederland BvUnilabs Holding Slovak/Alpha MedicalUNILABS LABORATOIRE D'ANAYLYSES MEDICALES SAUnilabs Laboratoire D'Anaylyses Medicales SaBoard members of Unilabs Diagnostics AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rannveig Börresen Krane | Chief Executive Officer | 0 companies |
| Adam Lars Alexander Ljungquist | Chief Auditor | 0 companies |
| Mikaela Ywonne Mars | Authorized Recipient of Service | 0 companies |
| Johan David Höglund | Chief Executive Officer | 0 companies |
| Lars Peter Wallqvist | Chief Executive Officer | 0 companies |
| Eva Marina Svensson | Chief Auditor | 0 companies |
| Anders Göran Magnussen | Chief Auditor | 0 companies |
| Simon Antoine Pierre Ginesty | Board of Directors | 0 companies |
| Michiel Anthonie Benjamin Boehmer | Chairman | 0 companies |
| Britt Ærbo Hendriksen | Chairman | 0 companies |
| Martin Schlatter | Board of Directors | 0 companies |
| Lars Linaa Jörgensen | Board of Directors | 0 companies |
| Arnaud Caurraze | Board of Directors | 0 companies |
| Carsten Michael Højlund | Chairman | 0 companies |
| Alessandre Martin Keller | Chairman | 0 companies |
| Sanna Kristina Maria Rydberg | Board of Directors | 0 companies |
| Victoria Louise Bell | Board of Directors | 0 companies |
| Andrew Mehul Derodra | Board of Directors | 0 companies |
| Robert Stacey Alfred Abbott | Board of Directors | 0 companies |
| Thomas Axel Per Lindahl | Board of Directors | 0 companies |
| Josephus Willhelmus Johannes Lamers | Chairman | 0 companies |
| Anders Fredrik Breitung | Board of Directors | 0 companies |